MedTrace Logo

Silver Nanoparticles in Multidrug Resistant Bacteria

NCT04431440 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2020-11-05

No results posted yet for this study

Summary

Recently, silver nanoparticles (AgNPs) have been widely used in various applications as antimicrobial agents, anticancer, diagnostics, biomarkers, cell labels, and drug delivery systems for the treatment of various diseases. The present study investigated the bactericidal effect of AgNPs against Methecillin Resistant Staph. aureus (MRSA) and Vancomycin resistant Staph aureus (VRSA)

Conditions

  • Multidrug Resistent Bacteria

Interventions

OTHER

silver nanoparticles

effect silver nanoparticles will be examined on multidrug resistant bacteria

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2020-10-05
Completion
2020-10-13

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04431440 on ClinicalTrials.gov